Tech Company Financing Transactions
Turnstone Biologics Funding Round
Turnstone Biologics, based in Ottawa Ontario, secured $41.4 million in investment from OrbiMed, F-Prime Capital and Versant Ventures.
Transaction Overview
Company Name
Announced On
11/3/2016
Transaction Type
Venture Equity
Amount
$41,400,000
Round
Series B
Investors
Proceeds Purpose
The series B will support completion of the ongoing Phase I/II trial, as well as fund three additional clinical programs that will start this year and next.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12 York St. 3rd Floor
Ottawa Ontario, K1N 5S6
Canada
Ottawa Ontario, K1N 5S6
Canada
Phone
Website
Email Address
Overview
Turnstone Biologics Inc. is a biotechnology company focused on developing novel oncolytic viral immunotherapies for cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sammy Farah
Chief Financial Officer
Jane Henderson
Vice President
Caroline Breitbach
VP - Human Resources
Kristin Gustafson
VP - Operations
José Otero
VP - R & D
Michael Burgess
VP - R & D
Brian Lichty
Browse more venture capital transactions:
Prev: 11/3/2016: Immusoft venture capital transaction
Next: 11/3/2016: Interana venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs